Loading...
Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
BACKGROUND: Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase A deficiency leading to renal, cardiac, cerebrovascular disease and premature death. Treatment with α-galactosidase A (enzyme replacement therapy, ERT) stabilises disease in some patients, but long term eff...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3626869/ https://ncbi.nlm.nih.gov/pubmed/23531228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-47 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|